Cargando…

Burden of Illness in Type 2 Diabetes Mellitus

An estimated 30.2 million Americans have diabetes, and this number is expected to increase based on trends over recent decades and compounded by an aging U.S. population. As reviewed in this article, type 2 diabetes mellitus (T2DM) is associated with impaired health-related quality of life (HRQoL) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cannon, Anthony, Handelsman, Yehuda, Heile, Michael, Shannon, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2018
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408423/ https://www.ncbi.nlm.nih.gov/pubmed/30156443 http://dx.doi.org/10.18553/jmcp.2018.24.9-a.s5

Ejemplares similares

Health-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus
por: Billings, Liana K., et al.
Publicado: (2018)

Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications
por: Heile, Michael, et al.
Publicado: (2018)

Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists
por: Handelsman, Yehuda, et al.
Publicado: (2018)

Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study
por: Tomaszewski, Kenneth J, et al.
Publicado: (2019)

Burden of Illness: Costs and Consequences of Our Fragmented Mental Health Care System
por: Arizpe, Michael, et al.
Publicado: (2006)

Corrections
por: Handelsman, Yehuda, et al.
Publicado: (2018)

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
por: Handelsman, Yehuda
Publicado: (2011)

Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
por: Handelsman, Yehuda
Publicado: (2019)

Type 2 Diabetes and Cardiovascular Disease: Reducing the Risk
por: Bartels, David W., et al.
Publicado: (2007)

Pregnancy as an opportunity to prevent type 2 diabetes mellitus: FIGO Best Practice Advice
por: Adam, Sumaiya, et al.
Publicado: (2023)

Identifying and meeting the challenges of insulin therapy in type 2 diabetes
por: Sorli, Christopher, et al.
Publicado: (2014)

PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
por: Handelsman, Yehuda, et al.
Publicado: (2018)

Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC()
por: Bloomgarden, Zachary, et al.
Publicado: (2020)

What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
por: Bonde, Lawrence, et al.
Publicado: (2006)

Managing Type 2 Diabetes: Going Beyond Glycemic Control
por: Stolar, Mark W., et al.
Publicado: (2008)

Trends in the Management of Type 2 Diabetes: An Emerging Role for Insulin
por: Braunstein, Seth N., et al.
Publicado: (2005)

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
por: Fonseca, Vivian A, et al.
Publicado: (2010)

Correlation of Lipid Profile and Glycated Hemoglobin as a New Prognostic Criterion for Type 2 Diabetes Mellitus Development and Progression
por: Zagrebin, E.A., et al.
Publicado: (2020)

Estimates of HIV burden in emergencies
por: Lowicki-Zucca, M, et al.
Publicado: (2008)

Incretin Mimetics: Promising New Therapeutic Options in the Treatment of Type 2 Diabetes
por: Gleeson, Jeremy M., et al.
Publicado: (2005)

The Changing Landscape of Type 2 Diabetes: The Role of Incretin-Based Therapies in Managed Care Outcomes
por: Triplitt, Curtis, et al.
Publicado: (2007)

Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study
por: Rosenson, Robert S., et al.
Publicado: (2019)

Higher Global Diet Quality Score Is Inversely Associated with Risk of Type 2 Diabetes in US Women
por: Fung, Teresa T, et al.
Publicado: (2021)

AHRQ’s Comparative Effectiveness Research on Oral Medications for Type 2 Diabetes: A Summary of the Key Findings
por: Bennett, Wendy L., et al.
Publicado: (2012)

Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease
por: Bektas, Meryem, et al.
Publicado: (2020)

Managed Care to Medicare: Sharing the Burden of Chronic Kidney Disease
por: Peter, Wendy St.
Publicado: (2007)

The non-fatal disease burden caused by type 2 diabetes in South Africa, 2009
por: Bertram, Melanie Y., et al.
Publicado: (2013)

AHRQ's Comparative Effectiveness Research on Premixed Insulin Analogues for Adults with Type 2 Diabetes: Understanding and Applying the Systematic Review Findings
por: Qayyum, Rehan, et al.
Publicado: (2011)

World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults
por: Korsten, Koos, et al.
Publicado: (2021)

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
por: Handelsman, Yehuda, et al.
Publicado: (2019)

Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study
por: Janssen, L. M. M., et al.
Publicado: (2020)

Correction to: Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
por: Handelsman, Yehuda, et al.
Publicado: (2019)

Burden of disability in type 2 diabetes mellitus and the moderating effects of physical activity
por: Oyewole, Olufemi O, et al.
Publicado: (2023)

The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)
por: Morgante, Francesca, et al.
Publicado: (2019)

Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects
por: Duprez, Daniel A, et al.
Publicado: (2020)

Application of the Global Diet Quality Score in Chinese Adults to Evaluate the Double Burden of Nutrient Inadequacy and Metabolic Syndrome
por: He, Yuna, et al.
Publicado: (2021)

The Role of Pharmaceuticals in Reducing Cardiometabolic Risk: Rethinking Pharmacy Benefit Design to Reduce the Burden on the Health Care System
por: Chao, Schumarry H., et al.
Publicado: (2006)

Review of type-2 diabetes mellitus illness perceptions and associations with illness management
por: Hatala, Samuel, et al.
Publicado: (2020)

Three Perspectives on the Impact of Comparative Effectiveness Research on Decision Making
por: Brixner, Diana I., et al.
Publicado: (2012)

The Value of Preventive Medicine: A Look at Vaccine Management
por: Armstrong, Edward P., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_6pa52do95dtmki7bcqmm6d91v2